

Horizon Discovery Reports "Solid" 2019 Ahead Of US Public Offering


(Sharecast News) - Gene editing and modulation firm Horizon Discovery expects full-year revenues to show some year-on-year improvement after a strong ...


Horizon Discovery Exercises Option To License Base Editing Technology


Horizon Discovery Pens Joint Venture With US DNA Researchers Mammoth


(Sharecast News) - Life sciences firm Horizon Discovery has signed a strategic collaboration deal with Mammoth Biosciences that will see the two compa...


(Sharecast News) - Gene editing and gene modulation technology company Horizon Discovery Group announced an agreement to divest its In Vivo business u...


Horizon Discovery Sells "Subscale" Unit In Vivo For Nominal Sum


(Sharecast News) - Tate & Lyle: Kepler Cheuvreux upgrades to hold with a target price of 720p.